|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| C07D 239/70 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2694072 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12764765.9 |
| Date of filing the European patent application | 2012-03-30 | |
| (97) | Date of publication of the European application | 2014-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
| (46) | Date of publication of the claims translation | 2018-02-12 |
| (86) | Number | PCT/US2012/031679 |
| Date | 2012-03-30 |
| (87) | Number | WO 2012/135759 |
| Date | 2012-10-04 |
| (30) | Number | Date | Country code |
| 201161470803 P | 2011-04-01 | US | |
| 201161470624 P | 2011-04-01 | US |
| (72) |
NANNINI, Michelle, US
SAMPATH, Deepak, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | AKT slopinančio junginio ir abiraterono derinys, skirtas naudoti terapiniam gydymui |
| COMBINATION OF AKT INHIBITOR COMPOUND AND ABIRATERONE FOR USE IN THERAPEUTIC TREATMENTS |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 15 | 289.00 EUR |
| 2027-03-30 |